Abstract
Abstract
Background
Social science research has demonstrated how health practitioners negotiate and contest professional roles and jurisdictions in practice, and in ways that reflect the power dynamics that permeate medicine. This article further explores these relational dynamics by examining how general practitioners (GPs) in Aotearoa New Zealand frame their working relationships with pharmacists.
Methods
We conducted semi-structured interviews with 16 GPs from around the country. Interviews had a mean duration of 46 min, and were thematically analysed.
Results
GPs saw and used pharmacists as a key source of information about both medicines and patients; thus it was not only pharmacists’ training and expertise, but also their community setting and patient proximity, that made them a useful resource to doctors. Furthermore, GPs framed pharmacists as a critical ‘safety net’ due to their role in catching errors and checking prescribing details. The pharmacy ‘safety net’ also came through in participants’ comments on discount pharmacies, which have introduced pronounced cost-cutting logics to Aotearoa New Zealand’s pharmaceutical landscape; in their reflections on these organisations, prescribers express the importance of robust pharmacy practice to their own work.
Conclusions
Whilst the literature often foregrounds tensions in how health providers reinscribe their professional roles, this research highlights the interdependence that doctors identify with pharmacists, and their aspirations for working together. Both professional groups navigate a pressed health system that presents a set of common challenges to good medicines practice.
Funder
Health Research Council of New Zealand
Pharmac
Reference45 articles.
1. Williamson DA, Heffernan H. The changing landscape of antimicrobial resistance in New Zealand. N Z Med J. 2014;127(1403):41–54.
2. Te Apārangi Royal Society of New Zealand. Antimicrobial resistance implications for New Zealanders [Internet]. 2017. https://www.royalsociety.org.nz/assets/documents/Antimicrobial-resistance-factsheet-May-2017.pdf. Accessed 5 Oct 2022.
3. Nind J, Smith A, Devananda M, Auvray B. A whole of population retrospective observational study on the rates of polypharmacy in New Zealand 2014 to 2018 Polypharmacy in New Zealand: What is the current status? Health Sci Rep. 2021;4(2): e263.
4. Hefford M, Crampton P, Foley J. Reducing health disparities through primary care reform: the New Zealand experiment. Health Policy. 2005;72(1):9–23.
5. Sheridan NF, Kenealy TW, Connolly MJ, Mahony F, Barber PA, Boyd MA, et al. Health equity in the New Zealand health care system: a national survey. Int J Equity Health. 2011;10(1):45.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献